Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a collaboration with the ...
Cellares has joined forces with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative ...
The global stem cell manufacturing market size was valued at USD 15.83 billion in 2025 and is predicted to hit around USD ...
Whether for drug screening or toxicity testing, stem cell-based 3D tissue models are key to biomedical research. However, ...
SOUTH SAN FRANCISCO, Calif. & LONDON--(BUSINESS WIRE)--Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation ...
Opportunities include the growing demand for scalable solutions to support the burgeoning cell and gene therapy pipeline, ...
Cell and Gene Therapy Catapult’s Stevenage Manufacturing Innovation Centre Photo credit: Cell and Gene Therapy Catapult The first facility, housed within the Cell and Gene Therapy Catapult’s (CGT ...
Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a $257 million Series D financing co--led by investment funds managed by BlackRock and Eclipse, ...
LONDON--(BUSINESS WIRE)--Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ ...
Cellares, which last year became the first company to receive the FDA's new advanced manufacturing technology designation, ...
Sony and Cellares announced a joint development collaboration Sept. 12. The two companies say the partnership aims to integrate Sony’s cell-sorting and analytical technologies into the Cell Shuttle, ...
Data integrity is key to the success of any cell therapy program. CDMOs can implement robust data management systems for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results